118 related articles for article (PubMed ID: 17170228)
1. Aromatase activity of human mesenchymal stem cells is stimulated by early differentiation, vitamin D and leptin.
Pino AM; Rodríguez JM; Ríos S; Astudillo P; Leiva L; Seitz G; Fernández M; Rodríguez JP
J Endocrinol; 2006 Dec; 191(3):715-25. PubMed ID: 17170228
[TBL] [Abstract][Full Text] [Related]
2. Increased adipogenesis of osteoporotic human-mesenchymal stem cells (MSCs) characterizes by impaired leptin action.
Astudillo P; Ríos S; Pastenes L; Pino AM; Rodríguez JP
J Cell Biochem; 2008 Mar; 103(4):1054-65. PubMed ID: 17973271
[TBL] [Abstract][Full Text] [Related]
3. The osteogenic or adipogenic lineage commitment of human mesenchymal stem cells is determined by protein kinase C delta.
Lee S; Cho HY; Bui HT; Kang D
BMC Cell Biol; 2014 Nov; 15():42. PubMed ID: 25420887
[TBL] [Abstract][Full Text] [Related]
4. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.
Bäckesjö CM; Li Y; Lindgren U; Haldosén LA
J Bone Miner Res; 2006 Jul; 21(7):993-1002. PubMed ID: 16813520
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-17A increases leptin production in human bone marrow mesenchymal stem cells.
Noh M
Biochem Pharmacol; 2012 Mar; 83(5):661-70. PubMed ID: 22197587
[TBL] [Abstract][Full Text] [Related]
6. Cooperation between TGF-beta and Wnt pathways during chondrocyte and adipocyte differentiation of human marrow stromal cells.
Zhou S; Eid K; Glowacki J
J Bone Miner Res; 2004 Mar; 19(3):463-70. PubMed ID: 15040835
[TBL] [Abstract][Full Text] [Related]
7. Osteo-transcriptomics of human mesenchymal stem cells: accelerated gene expression and osteoblast differentiation induced by vitamin D reveals c-MYC as an enhancer of BMP2-induced osteogenesis.
Piek E; Sleumer LS; van Someren EP; Heuver L; de Haan JR; de Grijs I; Gilissen C; Hendriks JM; van Ravestein-van Os RI; Bauerschmidt S; Dechering KJ; van Zoelen EJ
Bone; 2010 Mar; 46(3):613-27. PubMed ID: 19857615
[TBL] [Abstract][Full Text] [Related]
8. Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression.
Zhang L; Su P; Xu C; Chen C; Liang A; Du K; Peng Y; Huang D
J Pineal Res; 2010 Nov; 49(4):364-72. PubMed ID: 20738756
[TBL] [Abstract][Full Text] [Related]
9. Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes.
Chen ZX; Chang M; Peng YL; Zhao L; Zhan YR; Wang LJ; Wang R
Regul Pept; 2007 Jul; 142(1-2):16-23. PubMed ID: 17331598
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P450 synergistically with dexamethasone depending on the vitamin D receptor level in cultured human osteoblasts.
Tanaka S; Haji M; Takayanagi R; Tanaka S; Sugioka Y; Nawata H
Endocrinology; 1996 May; 137(5):1860-9. PubMed ID: 8612525
[TBL] [Abstract][Full Text] [Related]
11. Human osteoblasts derived from mesenchymal stem cells express adipogenic markers upon coculture with bone marrow adipocytes.
Clabaut A; Delplace S; Chauveau C; Hardouin P; Broux O
Differentiation; 2010 Jul; 80(1):40-5. PubMed ID: 20466479
[TBL] [Abstract][Full Text] [Related]
12. Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes.
Gharibi B; Abraham AA; Ham J; Evans BA
J Bone Miner Res; 2011 Sep; 26(9):2112-24. PubMed ID: 21590734
[TBL] [Abstract][Full Text] [Related]
13. EMF acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes.
Yang Y; Tao C; Zhao D; Li F; Zhao W; Wu H
Bioelectromagnetics; 2010 May; 31(4):277-85. PubMed ID: 20041434
[TBL] [Abstract][Full Text] [Related]
14. Osteogenic differentiation of human mesenchymal stem cells cultured with dexamethasone, vitamin D3, basic fibroblast growth factor, and bone morphogenetic protein-2.
Mostafa NZ; Fitzsimmons R; Major PW; Adesida A; Jomha N; Jiang H; Uludağ H
Connect Tissue Res; 2012; 53(2):117-31. PubMed ID: 21966879
[TBL] [Abstract][Full Text] [Related]
15. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity.
Lee NJ; Doyle KL; Sainsbury A; Enriquez RF; Hort YJ; Riepler SJ; Baldock PA; Herzog H
J Bone Miner Res; 2010 Aug; 25(8):1736-47. PubMed ID: 20200977
[TBL] [Abstract][Full Text] [Related]
16. Human mesenchymal stem cells as an in vitro model for human adipogenesis.
Janderová L; McNeil M; Murrell AN; Mynatt RL; Smith SR
Obes Res; 2003 Jan; 11(1):65-74. PubMed ID: 12529487
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of adipogenic and osteogenic differentiation of human bone-marrow-derived mesenchymal stem cells by supplementation with umbilical cord blood serum.
Tekkatte C; Vidyasekar P; Kapadia NK; Verma RS
Cell Tissue Res; 2012 Feb; 347(2):383-95. PubMed ID: 22311206
[TBL] [Abstract][Full Text] [Related]
18. Development of a rapid culture method to induce adipocyte differentiation of human bone marrow-derived mesenchymal stem cells.
Ninomiya Y; Sugahara-Yamashita Y; Nakachi Y; Tokuzawa Y; Okazaki Y; Nishiyama M
Biochem Biophys Res Commun; 2010 Apr; 394(2):303-8. PubMed ID: 20206132
[TBL] [Abstract][Full Text] [Related]
19. Human bone marrow-derived stem cell proliferation is inhibited by hepatocyte growth factor via increasing the cell cycle inhibitors p53, p21 and p27.
Chen K; Perez-Stable C; D'Ippolito G; Schiller PC; Roos BA; Howard GA
Bone; 2011 Dec; 49(6):1194-204. PubMed ID: 21907315
[TBL] [Abstract][Full Text] [Related]
20. Efficient engineering of vascularized ectopic bone from human embryonic stem cell-derived mesenchymal stem cells.
Domev H; Amit M; Laevsky I; Dar A; Itskovitz-Eldor J
Tissue Eng Part A; 2012 Nov; 18(21-22):2290-302. PubMed ID: 22731654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
